nach oben

Diabetologia

Erschienen in:

01.07.2005 | Article

Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction

verfasst von: H. Farhangkhoee, Z. A. Khan, Y. Barbin, S. Chakrabarti

Erschienen in: Diabetologia | Ausgabe 7/2005

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Hyperglycaemia-induced oxidative stress is implicated in the pathogenesis of chronic diabetic complications. Glucose-mediated oxidation of LDL may result in increased oxidative stress and vascular endothelial cell dysfunction via interaction with a cell surface scavenger receptor, CD36. In this study, we investigated the role of CD36 in cultured microvascular endothelial cells (MVECs) and in the heart by using an animal model of chronic diabetes.

Methods

Cultured MVECs were subjected to varying glucose concentrations and assayed for alteration in CD36 gene expression and protein levels. To assess for oxidised LDL (ox-LDL) uptake, MVECs exposed to low and high glucose were treated with ox-LDL (80 μg/ml), a ligand for CD36. Haem oxygenase-1 (HO-1) and endothelin-1 (ET-1) induction, as well as oxidative stress were determined. The role of glucose-induced CD36 alteration in ox-LDL uptake was also assayed following post-transcriptional CD36 gene silencing. For in vivo studies, CD36 mRNA and oxidative DNA and protein damage were measured in heart tissues of 1-month-old diabetic Sprague–Dawley rats.

Results

We found that glucose increased CD36 mRNA and protein levels in MVECs. High levels of glucose also augmented ox-LDL uptake, in association with increasing HO-1 and ET-1 mRNA levels. CD36 gene silencing prevented glucose-induced CD36 alteration, reduced ox-LDL uptake, and prevented HO-1 and ET-1 up-regulation. Similar to in vitro studies, diabetic heart tissues exhibited increased CD36 mRNA levels and increased oxidative DNA and protein damage.

Conclusions/interpretation

Our results provide evidence that up-regulation of CD36 may have a role in increasing oxidative stress in MVECs and the heart in chronic diabetes.

Harris MI (1998) Diabetes in America: epidemiology and scope of the problem. Diabetes Care 21:C11–C14PubMed

International Diabetes Federation (2003) Diabetes atlas, 2nd edn. International Diabetes Federation, Brussels, Belgium

Aleksandrovski YA (1998) Molecular mechanisms of diabetic complications. Biochemistry (Mosc) 63:1249–1257

Sheetz MJ, King GL (2002) Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA 288:2579–2588CrossRefPubMed

Hamby RI, Zoneraich S, Sherman L (1974) Diabetic cardiomyopathy. JAMA 229:1749–1754CrossRefPubMed

Rodrigues B, McNeill JH (1992) The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res 26:913–922PubMed

Giugliano D, Ceriello A, Paolisso G (1995) Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism 44:363–368CrossRefPubMed

Nishikawa T, Edelstein D, Du XL et al (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790PubMed

Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1–9PubMed

10.

Nadler J, Winer L (1996) Free radicals, nitric oxide and diabetic complications. In: LeRoith D, Taylor SI, Olefsky M (eds) Diabetes mellitus. Lippincott-Raven, Philadelphia, PA, pp 840–848

11.

Cadenas E (1989) Biochemistry of oxygen toxicity. Annu Rev Biochem 58:79–110

12.

Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H (1993) Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci U S A 90:6434–6438PubMed

13.

Griffin E, Re A, Hamel N et al (2001) A link between diabetes and atherosclerosis: glucose regulates expression of CD36 at the level of translation. Nat Med 7:840–846CrossRefPubMed

14.

Tsuzura S, Ikeda Y, Suehiro T et al (2004) Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism 53:297–302CrossRefPubMed

15.

Cohen MP, Lautenslager G, Shea E (1993) Glycated LDL concentrations in non-diabetic and diabetic subjects measured with monoclonal antibodies reactive with glycated apolipoprotein B epitopes. Eur J Clin Chem Clin Biochem 31:707–713PubMed

16.

Steinbrecher UP, Witztum JL (1984) Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 33:130–134PubMed

17.

Klein RL, Laimins M, Lopes-Virella MF (1995) Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects. Diabetes 44:1093–1098PubMed

18.

Boullier A, Bird DA, Chang MK et al (2001) Scavenger receptors, oxidized LDL, and atherosclerosis. Ann N Y Acad Sci 947:214–222PubMed

19.

Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA (1993) CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268:221–236PubMed

20.

Tandon NN, Lipsky RH, Burgess WH, Jamieson GA (1989) Isolation and characterization of platelet glycoprotein IV (CD36). J Biol Chem 264:7570–7575PubMed

21.

Abumrad NA, el Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA (1993) Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268:17665–17668PubMed

22.

Greenwalt DE, Scheck SH, Rhinehart-Jones T (1995) Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J Clin Invest 96:1382–1388

23.

Miyazaki A, Nakayama H, Horiuchi S (2002) Scavenger receptors that recognize advanced glycation end products. Trends Cardiovasc Med 12:258–262CrossRefPubMed

24.

Khan ZA, Cukiernik M, Gonder JR, Chakrabarti S (2004) Oncofetal fibronectin in diabetic retinopathy. Invest Ophthalmol Vis Sci 45:287–295CrossRefPubMed

25.

Liu WL, Guo X, Guo ZG (1998) Oxidized low-density lipoproteins induce apoptosis in vascular smooth muscle cells. Zhongguo Yao Li Xue Bao 19:245–247PubMed

26.

Chow SE, Chu WK, Shih SH, Chen JK (2002) Exposure to oxidized low-density lipoprotein reduces activable Ras protein in vascular endothelial cells. In Vitro Cell Dev Biol Anim 38:320–325CrossRefPubMed

27.

Kamalvand G, Pinard G, Ali-Khan Z (2003) Heme-oxygenase-1 response, a marker of oxidative stress, in a mouse model of AA amyloidosis. Amyloid 10:151–159PubMed

28.

Tyrrell RM, Basu-Modak S (1994) Transient enhancement of heme oxygenase 1 mRNA accumulation: a marker of oxidative stress to eukaryotic cells. Methods Enzymol 234:224–235PubMed

29.

Khan ZA, Chakrabarti S (2003) Endothelins in chronic diabetic complications. Can J Physiol Pharm 81:622–634CrossRef

30.

Farhangkhoee H, Khan ZA, Mukherjee S et al (2003) Heme oxygenase in diabetes-induced oxidative stress in the heart. J Mol Cell Cardiol 35:1439–1448CrossRefPubMed

31.

Chen S, Khan ZA, Barbin Y, Chakrabarti S (2004) Pro-oxidant role of heme oxygenase in mediating glucose-induced endothelial cell damage. Free Radic Res 38:1301–1310CrossRefPubMed

32.

Rodrigues B, McNeill JH (1999) Physiological and pathological consequences of streptozotocin diabetes on the heart. In: McNeill JH (ed) Experimental model of diabetes. CRC Press LLC, Boca Raton, FL, pp 63–80

33.

Piconi L, Quagliaro L, Ceriello A (2003) Oxidative stress in diabetes. Clin Chem Lab Med 41:1144–1149

34.

Abu-Qare AW, Abou-Donia MB (2001) Combined exposure to sarin and pyridostigmine bromide increased levels of rat urinary 3-nitrotyrosine and 8-hydroxy-2′-deoxyguanosine, biomarkers of oxidative stress. Toxicol Lett 123:51–58CrossRefPubMed

35.

Luiken JJ, Arumugam Y, Bell RC et al. (2002) Changes in fatty acid transport and transporters are related to the severity of insulin deficiency. Am J Physiol Endocrinol Metabol 283:E612–E621

36.

Sampson MJ, Davies IR, Braschi S, Ivory K, Hughes DA (2003) Increased expression of a scavenger receptor (CD36) in monocytes from subjects with type 2 diabetes. Atherosclerosis 167:129–134CrossRefPubMed

37.

Maziere C, Meignotte A, Dantin F, Conte MA, Maziere JC (2000) Oxidized LDL induces an oxidative stress and activates the tumor suppressor p53 in MRC5 human fibroblasts. Biochem Biophys Res Commun 276:718–723CrossRefPubMed

Titel: Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction
verfasst von: H. Farhangkhoee
Z. A. Khan
Y. Barbin
S. Chakrabarti
Publikationsdatum: 01.07.2005
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 7/2005
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-005-1801-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2005

To: Wannamethee SG, Lowe GDO, Shaper AG, Rumley A, Lennon L, Whincup PH (2004) Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease. Diabetologia 47:1557–1565

Single nucleotide polymorphisms in the gene encoding Krüppel-like factor 7 are associated with type 2 diabetes

Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome

Insulin resistance and the metabolic syndrome

Polymorphism of the solute carrier family 12 (sodium/chloride transporters) member 3, SLC12A3, gene at exon 23 (+78G/A: Arg913Gln) is associated with elevation of urinary albumin excretion in Japanese patients with type 2 diabetes: a 10-year longitudinal study

Coffee, diabetes and insulin sensitivity

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Update Innere Medizin